The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127694871 12769487 1 I 20160225 20160921 20160921 EXP CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-015683 BRISTOL MYERS SQUIBB 0.00 F Y 0.00000 20160921 CN CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127694871 12769487 1 PS ORENCIA ABATACEPT 1 Unknown N 125118
127694871 12769487 2 SS TYLENOL ACETAMINOPHEN 1 Unknown AS NEEDED U 0
127694871 12769487 3 SS ENBREL ETANERCEPT 1 Unknown 50 MG, QWK(LOE) N 0 50 MG /wk
127694871 12769487 4 SS SULFASALAZINE. SULFASALAZINE 1 Oral 2000 MG(INTOLERANCE) N 0 2000 MG
127694871 12769487 5 SS ACTEMRA TOCILIZUMAB 1 Unknown U 0
127694871 12769487 6 SS ARAVA LEFLUNOMIDE 1 Unknown 20 MG, QD U 0 20 MG TABLET QD
127694871 12769487 7 SS CIMZIA CERTOLIZUMAB PEGOL 1 Subcutaneous U 0
127694871 12769487 8 SS SIMPONI GOLIMUMAB 1 Subcutaneous U 0
127694871 12769487 9 SS HUMIRA ADALIMUMAB 1 Subcutaneous U 0
127694871 12769487 10 SS PLAQUENIL /00072602/ HYDROXYCHLOROQUINE DIPHOSPHATE 1 Unknown 200 MG, BID U 0 200 MG TABLET BID
127694871 12769487 11 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) U 0
127694871 12769487 12 SS RITUXAN RITUXIMAB 1 Intravenous (not otherwise specified) U 0
127694871 12769487 13 C METHOTREXATE. METHOTREXATE 1 Unknown 25 MG/ML, QWK U 0 25 DF /wk
127694871 12769487 14 C MELOXICAM. MELOXICAM 1 Unknown U 0
127694871 12769487 15 C SYNTHROID LEVOTHYROXINE SODIUM 1 Unknown U 0
127694871 12769487 16 C TYLENOL WITH CODEINE ACETAMINOPHENCODEINE PHOSPHATE 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127694871 12769487 1 Rheumatoid arthritis
127694871 12769487 2 Product used for unknown indication
127694871 12769487 3 Rheumatoid arthritis
127694871 12769487 4 Product used for unknown indication
127694871 12769487 5 Rheumatoid arthritis
127694871 12769487 6 Rheumatoid arthritis
127694871 12769487 7 Product used for unknown indication
127694871 12769487 8 Product used for unknown indication
127694871 12769487 9 Rheumatoid arthritis
127694871 12769487 10 Rheumatoid arthritis
127694871 12769487 11 Rheumatoid arthritis
127694871 12769487 12 Rheumatoid arthritis
127694871 12769487 13 Rheumatoid arthritis
127694871 12769487 14 Product used for unknown indication
127694871 12769487 15 Product used for unknown indication
127694871 12769487 16 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
127694871 12769487 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127694871 12769487 Activities of daily living impaired
127694871 12769487 Condition aggravated
127694871 12769487 Drug ineffective
127694871 12769487 Drug intolerance
127694871 12769487 Fatigue
127694871 12769487 Gait disturbance
127694871 12769487 Somnolence
127694871 12769487 Visual impairment

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127694871 12769487 3 200310 200706 0
127694871 12769487 4 200707 200712 0
127694871 12769487 13 2001 0